The pharmacy residency in Solid Organ Transplantation will be offered to candidates who desire to advance their knowledge and skills in solid organ transplant pharmacotherapy. This 12-month residency program builds on experiences gained in the PGY1 year and is designed to provide a well-rounded experience leading to the development of expert knowledge, skills, and clinical leadership in the practice of solid organ transplant pharmacy.
We offer a flexible program that focuses on the goals of each resident, but is intended to provide a comprehensive clinical, research, and teaching experience.
Training opportunities are provided through a variety of clinical rotations and interactions with multidisciplinary healthcare teams that deliver seamless, comprehensive care to transplant recipients from pre-transplant evaluation to post-operative and lifelong follow-up. Throughout the year the resident participates in clinical practice with required rotations in adult heart, liver, lung, renal, pancreas, and small bowel transplant services. Residents also have opportunities to complete elective rotations in areas of pediatric transplantation, transplant infectious diseases, critical care, and transplant research. Along with excellence in clinical care, NewYork-Presbyterian Hospital is committed to the ongoing progress of transplantation through rigorous scientific research. Residents will have the opportunity to participate in investigator-initiated research studies as well as Phase 2 and Phase 3 clinical trials of investigational immunosuppressants.
Additional learning experiences include completion of a major project and a medication use evaluation. Residents also participate in activities of the Solid Organ Transplant Formulary and Therapeutics subcommittee. The resident will develop teaching skills by providing in-service presentations to pharmacy staff and other health care providers, precepting PGY1 residents and pharmacy students, leading case-based clinical discussions, and critically evaluating literature
Upon completion of the program, the resident is expected to demonstrate competency in the area of transplant pharmacy practice, written and oral communication, and transplant clinical research.
This residency participates in the American Society of Health-System Pharmacists Residency Matching Program and is fully accredited by ASHP.
Applicants must have graduated from an accredited Doctor of Pharmacy (PharmD) program and completed an ASHP-accredited PGY-1 pharmacy practice residency prior to beginning this Solid Organ Transplantation PGY-2 pharmacy residency. Applicants must also be eligible for licensure in New York State.
NewYork-Presbyterian Hospital Residency Programs participate in the ASHP-associated Pharmacy Online Residency Centralized Application Service (PhORCAS) for applications and the National Matching Service (NMS) for the residency matching process. Required documents should be submitted through PhORCAS by January 8th. Required documents include:
More details on the use of PhORCAS can be found at ashp.org.
Paper applications may be accepted under unusual circumstances through special arrangement with the Residency Program Director.
Department of Pharmacy
622 West 168th Street
New York, NY 10032